MDS Completes Sale of Late-Stage Pharma Services Group | GenomeWeb

NEW YORK (GenomeWeb News) – Toronto-based MDS said today that it has completed the divestiture of its Phase II-IV Pharma Services operations to INC Research, a contract research organization based in Raleigh, NC.

Under the terms of the agreement, INC Research has acquired MDS Pharma Services' Phase II-IV operations, which includes approximately 800 employees who conduct clinical trials in more than 25 countries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: canine GWAS of skeletal syndromes, Chagas disease outcomes and genetic ancestry, and more.

A team describes its idea for a clinical trial data-sharing database, called Vivli, ScienceInsider reports.

One case illustrates how DNA evidence can incriminate an innocent person, Scientific American says.

A lack of stability in research funding drives researchers away from academia, researchers write at eLife.